Although this prognostic model constructed solely with BNIP3, MDM2, and RRM2 is relatively one-sided, the findings deepen the understanding of MDS pathogenesis, improve risk stratification, and build a more precise MDS prognostic system (Chen et al., 2023). The gene discussed is RRM2; the disease is myelodysplastic syndrome.